NCT07613320

Brief Summary

This study aims to evaluate bone and soft tissue changes clinically and digitally after using customized healing Abutment with or without silicate-added beta-tricalcium phosphate (Si-β-TCP) putty

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
0mo left

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress93%
Dec 2025Jul 2026

Study Start

First participant enrolled

December 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 22, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
3 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

May 29, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 22, 2026

Last Update Submit

May 22, 2026

Conditions

Keywords

Immediate implant placementFully-guided surgeryEsthetic zoneCustomized healing abutmentSi-β-TCP putty

Outcome Measures

Primary Outcomes (2)

  • Implant stability

    Implant stability will be evaluated using Osstell device based on resonance frequency analysis (ISQ values).

    Immediate post-operative, 3 months, and 6 months.

  • Hard Tissue (Peri-implant bone)

    Marginal bone loss will be assessed using CBCT measured in mm.

    - Preoperative (baseline) - Immediately after implant placement - 6 months after implant placement

Secondary Outcomes (1)

  • Soft Tissue

    Baseline, 1 month, 3 months, and 6 months.

Study Arms (2)

Control group

EXPERIMENTAL

Immediate implant placement with customized healing abutment without Si-β-TCP putty in the esthetic zone

Procedure: Conventional healing/ No graft

Study group (Si-β-TCP Putty Group)

EXPERIMENTAL

Immediate implant placement with silicate-added beta-tricalcium phosphate putty and customized healing abutment in the esthetic zone.

Procedure: Silicate-added β-TCP putty for jumping gap grafting

Interventions

Application of silicate-added beta-tricalcium phosphate putty in the jumping gap around fully-guided immediate implants placed in the esthetic zone, combined with provisional crown as acustomized healing abutment to enhance peri-implant soft tissue healing and ridge preservation.

Study group (Si-β-TCP Putty Group)

Standard fully-guided implant placement protocol without the use of bone graft material allowing natural healing of the jumping gap around immediately placed implants in the esthetic zone.

Control group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with non-restorable teeth in maxillary esthetic zone requiring dental extraction.
  • Adequate inter-arch relation and inter-occlusal space to accommodate the prosthetic restoration.
  • Jumping gap more than 2mm.
  • Patients with good oral hygiene.
  • Patients willing to participate in the study's follow-up intervals.

You may not qualify if:

  • Patients with any pathological lesion or aggressive periodontal disease at the planned surgical site impaired the immediate implant placement.
  • Alcohol or drug abuse.
  • Smokers.
  • Patients with systemic diseases that absolutely contraindicate implant placement (bleeding disorders, immunosuppression,…etc.)
  • Pregnancy.
  • Patients with para-functional habits (bruxism and clenching).
  • Lack of motivation or inability to maintain good oral hygiene.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry Mansoura University

Al Mansurah, Dakahlia Governorate, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 22, 2026

First Posted

May 29, 2026

Study Start

December 1, 2025

Primary Completion

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

May 29, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations